Staining intensity of brain iron in patients with schizophrenia

A postmortem study

M. F. Casanova, S. O. Comparini, R. W. Kim, Joel Kleinman

Research output: Contribution to journalArticle

Abstract

Evidence derived from both pharmacological and postmortem studies suggests that a disturbance of brain iron metabolism is involved in the pathophysiology of schizophrenia; i.e., the distribution of iron parallels that of dopamine, and variations in its brain concentration selectively modulate the binding affinity of the dopaminergic (D2) receptor. In the present study the authors examined the staining intensity of brain iron in postmortem specimens of 9 schizophrenic (SC) patients and 17 age-matched controls. Coronal sections were stained with the Perls's technique, photographed, and then studied using a computerized image analysis system. Optical density measurements were taken from the caudate nucleus, putamen, globus pallidus, and substantia nigra. This study revealed significant differences between groups only for the staining intensity of iron in the caudate nucleus (P < 0.005). A review of the literature suggests that this finding may be the result of neuroleptic therapy and not a primary pathological feature of schizophrenia.

Original languageEnglish (US)
Pages (from-to)36-41
Number of pages6
JournalJournal of Neuropsychiatry and Clinical Neurosciences
Volume4
Issue number1
StatePublished - 1992
Externally publishedYes

Fingerprint

Schizophrenia
Iron
Staining and Labeling
Caudate Nucleus
Brain
Globus Pallidus
Putamen
Substantia Nigra
Antipsychotic Agents
Dopamine
Pharmacology
Therapeutics

ASJC Scopus subject areas

  • Neuroscience(all)
  • Neuropsychology and Physiological Psychology

Cite this

Staining intensity of brain iron in patients with schizophrenia : A postmortem study. / Casanova, M. F.; Comparini, S. O.; Kim, R. W.; Kleinman, Joel.

In: Journal of Neuropsychiatry and Clinical Neurosciences, Vol. 4, No. 1, 1992, p. 36-41.

Research output: Contribution to journalArticle

@article{7862377594944eb493de9c659c6e71db,
title = "Staining intensity of brain iron in patients with schizophrenia: A postmortem study",
abstract = "Evidence derived from both pharmacological and postmortem studies suggests that a disturbance of brain iron metabolism is involved in the pathophysiology of schizophrenia; i.e., the distribution of iron parallels that of dopamine, and variations in its brain concentration selectively modulate the binding affinity of the dopaminergic (D2) receptor. In the present study the authors examined the staining intensity of brain iron in postmortem specimens of 9 schizophrenic (SC) patients and 17 age-matched controls. Coronal sections were stained with the Perls's technique, photographed, and then studied using a computerized image analysis system. Optical density measurements were taken from the caudate nucleus, putamen, globus pallidus, and substantia nigra. This study revealed significant differences between groups only for the staining intensity of iron in the caudate nucleus (P < 0.005). A review of the literature suggests that this finding may be the result of neuroleptic therapy and not a primary pathological feature of schizophrenia.",
author = "Casanova, {M. F.} and Comparini, {S. O.} and Kim, {R. W.} and Joel Kleinman",
year = "1992",
language = "English (US)",
volume = "4",
pages = "36--41",
journal = "Journal of Neuropsychiatry and Clinical Neurosciences",
issn = "0895-0172",
publisher = "American Psychiatric Publishing Inc.",
number = "1",

}

TY - JOUR

T1 - Staining intensity of brain iron in patients with schizophrenia

T2 - A postmortem study

AU - Casanova, M. F.

AU - Comparini, S. O.

AU - Kim, R. W.

AU - Kleinman, Joel

PY - 1992

Y1 - 1992

N2 - Evidence derived from both pharmacological and postmortem studies suggests that a disturbance of brain iron metabolism is involved in the pathophysiology of schizophrenia; i.e., the distribution of iron parallels that of dopamine, and variations in its brain concentration selectively modulate the binding affinity of the dopaminergic (D2) receptor. In the present study the authors examined the staining intensity of brain iron in postmortem specimens of 9 schizophrenic (SC) patients and 17 age-matched controls. Coronal sections were stained with the Perls's technique, photographed, and then studied using a computerized image analysis system. Optical density measurements were taken from the caudate nucleus, putamen, globus pallidus, and substantia nigra. This study revealed significant differences between groups only for the staining intensity of iron in the caudate nucleus (P < 0.005). A review of the literature suggests that this finding may be the result of neuroleptic therapy and not a primary pathological feature of schizophrenia.

AB - Evidence derived from both pharmacological and postmortem studies suggests that a disturbance of brain iron metabolism is involved in the pathophysiology of schizophrenia; i.e., the distribution of iron parallels that of dopamine, and variations in its brain concentration selectively modulate the binding affinity of the dopaminergic (D2) receptor. In the present study the authors examined the staining intensity of brain iron in postmortem specimens of 9 schizophrenic (SC) patients and 17 age-matched controls. Coronal sections were stained with the Perls's technique, photographed, and then studied using a computerized image analysis system. Optical density measurements were taken from the caudate nucleus, putamen, globus pallidus, and substantia nigra. This study revealed significant differences between groups only for the staining intensity of iron in the caudate nucleus (P < 0.005). A review of the literature suggests that this finding may be the result of neuroleptic therapy and not a primary pathological feature of schizophrenia.

UR - http://www.scopus.com/inward/record.url?scp=0026591412&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026591412&partnerID=8YFLogxK

M3 - Article

VL - 4

SP - 36

EP - 41

JO - Journal of Neuropsychiatry and Clinical Neurosciences

JF - Journal of Neuropsychiatry and Clinical Neurosciences

SN - 0895-0172

IS - 1

ER -